Inflammatory mediators and growth factors in obstructive renal injury

Journal of Surgical Research

Volumn 119, Issue 2, 2004, Pages 149-159

  Misseri, Rosalia ^a   Rink, Richard C ^a   Meldrum, Daniel R ^a   Meldrum, Kirstan K ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

apoptosis; kidney; tubulointerstitial fibrosis

Indexed keywords

ANGIOTENSIN; AUTACOID; CASPASE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL DEATH; INFLAMMATION; KIDNEY CELL; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; URINARY TRACT; URINARY TRACT OBSTRUCTION;

ANIMALS; GROWTH SUBSTANCES; HUMANS; INFLAMMATION MEDIATORS; KIDNEY DISEASES; URETERAL OBSTRUCTION;

EID: 2442490246     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2004.02.016     Document Type: Review

References (117)

1. Klahr S., Morrissey J.J. The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy. Semin. Nephrol. 18:1998;622
2. Gobe G.C., Axelsen R.A. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab. Invest. 56:1987;273
3. Chevalier R.L., Chung K.H., Smith C.D., et al. Renal apoptosis and clusterin following ureteral obstruction The role of maturation. J. Urol. 156:1996;1474
4. Morrissey J.J., Ishidoya S., McCracken R., et al. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int. Suppl. 54:1996;S83
5. Engelmyer E., van Goor H., Edwards D.R., et al. Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis. J. Am. Soc. Nephrol. 5:1995;1675
6. Alvarez R.J., Sun M.J., Haverty T.P., et al. Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int. 41:1992;14
7. Humes H.D., Cieslinski D.A. Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp. Cell Res. 201:1992;8
8. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N. Eng.l J. Med. 331:1994;1286
9. Eddy A.A. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 7:1996;2495
10. Roberts A.B., McCune B.K., Sporn M.B. TGF-beta Regulation of extracellular matrix. Kidney Int. 41:1992;557
11. Miyajima A., Chen J., Lawrence C., et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 58:2000;2301
12. Hewitson T.D., Tait M.G., Kelynack K.J., et al. Dipyridamole inhibits in vitro renal fibroblast proliferation and collagen synthesis. J. Lab. Clin. Med. 140:2002;199
13. Ishidoya S., Morrissey J., McCracken R., et al. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int. 49:1996;1110
14. Diamond J.R., Ricardo S.D., Klahr S. Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin. Nephrol. 18:1998;594
15. Massague J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 14:2000;627
16. Crawford S.E., Stellmach V., Murphy-Ullrich J.E., et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell. 93:1998;1159
17. Mirza A., Liu S.L., Frizell E., et al. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am. J. Physiol. 272:1997;G281
18. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14:2000;163
19. Schnaper H.W., Hayashida T., Poncelet A.C. It's a Smad world Regulation of TGF-beta signaling in the kidney. J. Am. Soc. Nephrol. 13:2002;1126
20. Chung K.H., Chevalier R.L. Arrested development of the neonatal kidney following chronic ureteral obstruction. J. Urol. 155:1996;1139
21. Walton G., Buttyan R., Garcia-Montes E., et al. Renal growth factor expression during the early phase of experimental hydronephrosis. J. Urol. 148:1992;510
22. Kaneto H., Morrissey J., Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int. 44:1993;313
23. Diamond J.R., Kees-Folts D., Ding G., et al. Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am. J. Physiol. 266:1994;F926
24. Sutaria P.M., Ohebshalom M., McCaffrey T.A., et al. Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sci. 62:1998;1965
25. Fukuda K., Yoshitomi K., Yanagida T., et al. Quantification of TGF-beta1 mRNA along rat nephron in obstructive nephropathy. Am. J. Physiol. Renal Physiol. 281:2001;F513
26. Schreiner G.F., Harris K.P., Purkerson M.L., et al. Immunological aspects of acute ureteral obstruction immune cell infiltrate in the kidney. Kidney Int. 34:1988;487
27. Diamond J.R., Levinson M., Kreisberg R., et al. Increased expression of decorin in experimental hydronephrosis. Kidney Int. 51:1997;1133
28. Kuncio G.S., Neilson E.G., Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 39:1991;550
29. Roberts A.B., Sporn M.B. Transforming growth factor beta. Adv. Cancer Res. 51:1988;107
30. Postlethwaite A.E., Keski-Oja J., Moses H.L., et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J. Exp. Med. 165:1987;251
31. Chandrasekhar S., Harvey A.K. Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem. Biophys. Res. Commun. 157:1988;1352
32. Vassalli J.D., Sappino A.P., Belin D. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1991;1067
33. Malyankar U.M., Almeida M., Johnson R.J., et al. Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int. 51:1997;1766
34. Chevalier R.L., Goyal S., Wolstenholme J.T., et al. Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor. Kidney Int. 54:1998;38
35. Ishidoya S., Morrissey J., McCracken R., et al. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int. 47:1995;1285
36. El-Dahr S.S., Gee J., Dipp S., et al. Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy. Am. J. Physiol. 264:1993;F874
37. Pimentel J.L. Jr, Martinez-Maldonado M., Wilcox J.N., et al. Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int. 44:1993;390
38. Pimentel J.L. Jr, Montero A., Wang S., et al. Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int. 48:1995;1247
39. Ricardo S.D., Levinson M.E., DeJoseph M.R., et al. Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int. 50:1996;2002
40. Klahr S., Harris K., Purkerson M.L. Effects of obstruction on renal functions. Pediatr. Nephrol. 2:1988;34
41. Klahr S. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am. J. Kidney Dis. 18:1991;689
42. Bernstein K.E., Berk B.C. The biology of angiotensin II receptors. Am. J. Kidney Dis. 22:1993;745
43. Meister B., Lippoldt A., Bunnemann B., et al. Cellular expression of angiotensin type-1 receptor mRNA in the kidney. Kidney Int. 44:1993;331
44. Sechi L.A., Grady E.F., Griffin C.A., et al. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am. J. Physiol. 262:1992;F236
45. Yoo K.H., Thornhill B.A., Wolstenholme J.T., et al. Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am. J. Hypertens. 11:1998;715
46. Klahr S., Morrissey J.J. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int. Suppl. 63:1997;S111
47. Guo G., Morrissey J., McCracken R., et al. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am. J. Physiol. Renal Physiol. 280:2001;F777
48. Morrissey J.J., Klahr S. Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am. J. Physiol. 274:1998;F580
49. Nakajima M., Hutchinson H.G., Fujinaga M., et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor Gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. USA. 92:1995;10663
50. Stoll M., Steckelings U.M., Paul M., et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95:1995;651
51. Tanaka M., Ohnishi J., Ozawa Y., et al. Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells. Biochem. Biophys. Res. Commun. 207:1995;593
52. Yamada T., Horiuchi M., Dzau V.J. Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. USA. 93:1996;156
53. Chevalier R.L., Thornhill B.A., Wolstenholme J.T. Renal cellular response to ureteral obstruction Role of maturation and angiotensin II. Am. J. Physiol. 277:1999;F41
54. Ma J., Nishimura H., Fogo A., et al. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int. 53:1998;937
55. Morrissey J.J., Klahr S. Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am. J. Physiol. 276:1999;F39
56. Klahr S., Morrissey J. Angiotensin II and gene expression in the kidney. Am. J. Kidney Dis. 31:1998;171
57. Haralambous-Gasser A., Chan D., Walker R.G., et al. Collagen studies in newborn rat kidneys with incomplete ureteric obstruction. Kidney Int. 44:1993;593
58. Pimentel J.L. Jr, Sundell C.L., Wang S., et al. Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney Int. 48:1995;1233
59. Kaneto H., Morrissey J., McCracken R., et al. The expression of mRNA for tumor necrosis factor-alpha increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrology. 2:1996;161
60. Morrissey J.J., Klahr S. Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int. 52:1997;926
61. Li J., Brasier A.R. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor One mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol. Endocrinol. 10:1996;252
62. Brasier A.R., Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension. 27:1996;465
63. Brasier A.R., Li J., Wimbish K.A. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension. 27:1996;1009
64. Bauerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:1994;141
65. Donnahoo K.K., Shames B.D., Harken A.H., et al. The role of tumor necrosis factor in renal ischemia-reperfusion injury. J. Urol. 162:1999;196. (Review)
66. Lenardo M.J., Baltimore D. NF-kappa B A pleiotropic mediator of inducible and tissue-specific gene control. Cell. 58:1989;227
67. Smale S.T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103
68. Morrissey J., Klahr S. Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction. Semin. Nephrol. 18:1998;603
69. Miyajima A., Kosaka T., Seta K., et al. Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J. Urol. 169:2003;1559
70. Hirahashi J., Takayanagi A., Hishikawa K., et al. Overexpression of truncated I kappa B alpha potentiates TNF-alpha-induced apoptosis in mesangial cells. Kidney Int. 57:2000;959
71. Sumitomo M., Tachibana M., Nakashima J., et al. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. J. Urol. 161:1999;674
72. Lang A., Schoonhoven R., Tuvia S., et al. Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J. Hepatol. 33:2000;49
73. Cross J.V., Deak J.C., Rich E.A., et al. Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis. J. Biol. Chem. 274:1999;31150
74. Beg A.A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:1996;782
75. Sugiyama H., Savill J.S., Kitamura M., et al. Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells. J. Biol. Chem. 274:1999;19532
76. Van Antwerp D.J., Martin S.J., Kafri T., et al. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 274:1996;787
77. Klahr S. Urinary tract obstruction. Semin. Nephrol. 21:2001;133
78. Ortiz A., Bustos C., Alonso J., et al. Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. Adv. Nephrol. Necker Hosp. 24:1995;53
79. Guo G., Morrissey J., McCracken R., et al. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am. J. Physiol. 277:1999;F766
80. Donnahoo K.K., Meng X., Ayala A., et al. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am. J. Physiol. 277:1999;R922
81. Donnahoo K.K., Meldrum D.R., Shenkar R., et al. Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J. Urol. 163:2000;1328
82. Meldrum K.K., Meldrum D.R., Hile K.L., et al. p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am. J. Physiol. Cell Physiol. 281:2001;C563
83. Meldrum K.K., Meldrum D.R., Hile K.L., et al. A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. J. Surg. Res. 99:2001;288
84. Donnahoo K.K., Meng X., Ao L., et al. Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxaemia. Immunology. 102:2001;53
85. Truong L.D., Sheikh-Hamad D., Chakraborty S., et al. Cell apoptosis and proliferation in obstructive uropathy. Semin. Nephrol. 18:1998;641
86. Farber J.L., Chien K.R., Mittnacht S. Jr. Myocardial ischemia The pathogenesis of irreversible cell injury in ischemia. Am. J. Pathol. 102:1981;271
87. Keane R.W., Kraydieh S., Lotocki G., et al. Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J. Cereb. Blood Flow Metab. 21:2001;1189
88. Ranganath R.M., Nagashree N.R. Role of programmed cell death in development. Int. Rev. Cytol. 202:2001;159
89. Saunders J.W. Jr. Death in embryonic systems. Science. 154:1966;604
90. Bellamy C.O., Malcomson R.D., Harrison D.J., et al. Cell death in health and disease The biology and regulation of apoptosis. Semin. Cancer Biol. 6:1995;3
91. Chalmers-Redman R.M., Fraser A.D., Ju W.Y., et al. Mechanisms of nerve cell death Apoptosis or necrosis after cerebral ischaemia. Int. Rev. Neurobiol. 40:1997;1
92. Schwarz C., Gruber U., Oberbauer R. Pathophysiology of acute renal failure at the cellular level. Wien Klin. Wochenschr. 112:2000;5
93. Wyllie A.H., Kerr J.F., Currie A.R. Cell death The significance of apoptosis. Int. Rev. Cytol. 68:1980;251
94. Choi Y.J., Baranowska-Daca E., Nguyen V., et al. Mechanism of chronic obstructive uropathy Increased expression of apoptosis-promoting molecules. Kidney Int. 58:2000;1481
95. Chevalier R.L., Smith C.D., Wolstenholme J., et al. Chronic ureteral obstruction in the rat suppresses renal tubular Bcl-2 and stimulates apoptosis. Exp. Nephrol. 8:2000;115
96. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6:1999;1028
97. Cohen G.M. Caspases The executioners of apoptosis. Biochem. J. 326:1997;1. (Pt 1)
98. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770
99. Zheng T.S., Hunot S., Kuida K., et al. Caspase knockouts Matters of life and death. Cell Death Differ. 6:1999;1043
100. Truong L.D., Choi Y.J., Tsao C.C., et al. Renal cell apoptosis in chronic obstructive uropathy The roles of caspases. Kidney Int. 60:2001;924
101. Kaushal G.P., Singh A.B., Shah S.V. Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am. J. Physiol. 274:1998;F587
102. Feldenberg L.R., Thevananther S., del Rio M., et al. Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. Am. J. Physiol. 276:1999;F837
103. Joza N., Kroemer G., Penninger J.M. Genetic analysis of the mammalian cell death machinery. Trends Genet. 18:2002;142
104. Miyajima A., Asano T., Yoshimura I., et al. Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. J Urol. 165:2001;1714
105. Kennedy W.A. 2nd, Buttyan R., Garcia-Montes E., et al. Epidermal growth factor suppresses renal tubular apoptosis following ureteral obstruction. Urology. 49:1997;973
106. Gao X., Mae H., Ayabe N., et al. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int. 62:2002;1238
107. Chevalier R.L., Goyal S., Kim A., et al. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1. Kidney Int. 57:2000;882
108. Nguyen H.T., Bride S.H., Badawy A.B., et al. Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis. Am. J. Pathol. 156:2000;889
109. Gerth J.H., Kriegsmann J., Trinh T.T., et al. Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II. Kidney Int. 61:2002;68
110. Horiuchi M., Hayashida W., Kambe T., et al. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272:1997;19022
111. Karin M., Cao Y., Greten F.R., et al. NF-kappaB in cancer From innocent bystander to major culprit. Nat. Rev. Cancer. 2:2002;301
112. Meldrum K.K., Burnett A.L., Meng X., et al. Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ. Res. 92:2003;293
113. Ishibashi N., Weisbrot-Lefkowitz M., Reuhl K., et al. Modulation of chemokine expression during ischemia/reperfusion in transgenic mice overproducing human glutathione peroxidases. J. Immunol. 163:1999;5666
114. Thevenod F., Friedmann J.M., Katsen A.D. Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J. Biol. Chem. 275:2000;1887
115. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NFkB activation. Cell. 81:1995;495
116. Chinnaiyan A.M., O'Rourke K., Tewari M., et al. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505
117. Tartaglia L.A., Weber R.F., Figari I.S., et al. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA. 88:1991;9292